Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

XPO Appoints Michael Kneeland to Board of Directors

XPO Appoints Michael Kneeland to Board of Directors

XPO, a leading North American freight transportation company, announces the appointment of Michael Kneeland to its board of directors. Kneeland brings extensive experience from his leadership roles at United Rentals and Gildan Activewear, adding valuable expertise to XPO's governance and strategic direction.

Diana Shipping Inc. Urges Genco Shipping & Trading to Stop Misleading Investors and Engage in Good Faith Negotiations

Diana Shipping Inc. Urges Genco Shipping & Trading to Stop Misleading Investors and Engage in Good Faith Negotiations

Diana Shipping Inc. announced the expiration and termination of its tender offer to acquire the outstanding shares of Genco Shipping & Trading Limited, citing a lack of substantive engagement from Genco's board. Despite offering a 53% premium over Genco's price before the initial proposal, Diana accuses Genco's board of misleading investors and sta…

Wetour Robotics to Enter into Warehouse Robotics Cooperation Agreement; Management Estimates Full Contemplated Rollout Could Generate Approximately US$5.0 Million in Project-Level Gross Profit

Wetour Robotics to Enter into Warehouse Robotics Cooperation Agreement; Management Estimates Full Contemplated Rollout Could Generate Approximately US$5.0 Million in Project-Level Gross Profit

Wetour Robotics Limited announced its U.S. subsidiary is seeking a cooperation agreement with a warehouse automation robotics company to support its multi-site Orchestra commercial project implementation. Management estimates the full project rollout could generate approximately $5 million in project-level gross profit, though the cooperation agree…

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

CAMP4 Therapeutics announced that it has received regulatory clearance from Australia's Therapeutic Goods Administration and Human Research Ethics Committee to commence the first-in-human clinical trial of CMP-002, a novel therapeutic targeting SYNGAP1-related disorder. This milestone triggers eligibility to raise up to $50 million in additional fu…

Fury Resumes Activities at Eau Claire

Fury Resumes Activities at Eau Claire

Fury Gold Mines Limited has resumed its exploration and drilling activities at the Eau Claire gold project in Northern Quebec after a precautionary suspension caused by a nearby wildfire. All personnel have returned safely, and the company confirms no material impact on its Phase 2 drilling program. Fury continues to prioritize safety and maintains…

SPX Announces Appointment of New Board Member

SPX Announces Appointment of New Board Member

SPX Technologies has appointed Brian Deck as a new independent member of its Board of Directors, effective July 27, 2026. Mr. Deck will also join the Audit and Governance & Sustainability Committees. Bringing extensive experience from his current role as CEO of JBT Marel Corporation and former leadership roles in finance and operations, his additio…

The Ensign Group Reports Second Quarter 2026 Results

The Ensign Group Reports Second Quarter 2026 Results

The Ensign Group, Inc., a US-based post-acute healthcare services provider, reported strong second quarter 2026 results with GAAP diluted EPS of $1.68 and adjusted EPS of $1.92, reflecting 16.7% and 20.8% growth year-over-year respectively. The company raised its 2026 annual earnings guidance to $7.75-$7.85 per diluted share and revenue guidance to…

Legend Biotech Announces CEO Transition

Legend Biotech Announces CEO Transition

Legend Biotech announced that Ying Huang, Ph.D., has stepped down as CEO and Board member, remaining as an advisor through August for a smooth transition. Alan Bash, President of the CARVYKTI Business Unit, is appointed Interim CEO, while the Board starts a search for a permanent CEO. The company remains focused on advancing its commercial, clinica…

Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company

Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company

Profusa, Inc., a digital health company specializing in next-generation biosensing technologies, announced key management changes including appointing Jack Stover as Executive Chairman and CEO and Ben Hwang moving to President. The company also signed a non-binding term sheet to acquire a privately held commercial-stage diagnostics company with pro…

VEON's Banglalink Demonstrates the Power of Digital Ecosystems with Record FIFA World Cup 2026 Engagement

VEON's Banglalink Demonstrates the Power of Digital Ecosystems with Record FIFA World Cup 2026 Engagement

VEON's subsidiary Banglalink reported unprecedented digital engagement metrics through its Toffee platform during the 39-day FIFA World Cup 2026. The platform achieved 2 billion live watch minutes, 20 million monthly active users, and significant advertiser interest, highlighting the rapid growth of digital ecosystems in Bangladesh and VEON's commi…

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline

argenx announced a definitive agreement to acquire Forte Biosciences for approximately $2.2 billion in cash, expanding its immunology portfolio with Forte's lead program FB102, a first-in-class anti-CD122 antibody showing promising Phase 1b clinical data in vitiligo and celiac disease. The acquisition complements argenx's existing antibody-based im…

Silvaco to Accelerate Physics-Based Digital Twins for Semiconductor Design and Manufacturing Using NVIDIA AI and Accelerated Computing

Silvaco to Accelerate Physics-Based Digital Twins for Semiconductor Design and Manufacturing Using NVIDIA AI and Accelerated Computing

Silvaco Group, Inc. announced a partnership with NVIDIA to develop advanced physics-based digital twins for semiconductor design and manufacturing. Leveraging NVIDIA's AI, CUDA-X libraries, and accelerated computing infrastructure, Silvaco aims to significantly speed up simulation runtimes, improve accuracy, and enable cloud-native, collaborative w…

Baker Hughes Announces Second-Quarter 2026 Results

Baker Hughes Announces Second-Quarter 2026 Results

Baker Hughes announced robust second-quarter 2026 financial results, highlighted by $10.5 billion in orders including a record $7.1 billion from its Industrial & Energy Technology (IET) segment. The company reported $6.7 billion in revenue, $681 million net income, and strong cash flow metrics. Growth was driven by strong demand across power system…

XFLT Proxy Contest: Why the Board Believes the King Street Sub-Adviser Will Be Beneficial for XFLT Shareholders

XFLT Proxy Contest: Why the Board Believes the King Street Sub-Adviser Will Be Beneficial for XFLT Shareholders

XAI Floating Rate & Alternative Income Trust (XFLT) announces the upcoming shareholder vote to approve King Street Capital Management's Rockford Tower Asset Management as the new investment sub-adviser. The Board unanimously supports this change, citing King Street's extensive CLO platform, experienced team, and potential for improved fund performa…

XFLT Proxy Vote: What This Shareholder Vote Is Really About

XFLT Proxy Vote: What This Shareholder Vote Is Really About

XAI Floating Rate & Alternative Income Trust (XFLT) has called a Special Meeting on July 30, 2026, for shareholders to vote on approving King Street Capital Management as the new investment sub-adviser. The Board supports King Street, believing this will enhance Fund performance and distributions without changing fees. The former sub-adviser, Octag…